Evidence map›Paper›PMID 40317680›Full record

ArticleAmerican journal of medical genetics. Part A2025

Further Delineation of the AUTS2 HX Repeat Domain-Related Phenotype.

Esin Nur Erdogan, Chi Vicky Cheng, Stefano G Caraffi, Ivan Ivanovski, Gianluca Piatelli, Edoardo Errichiello, Antigone S Papavasiliou, Georgia Vasileiou, André Reis, Bradley Prince and 24 more

Abstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Esin Nur ErdoganNorcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Chi Vicky ChengNorcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Stefano G CaraffiMedical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.ORCID 0000-0002-5033-7854
Ivan IvanovskiMedical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Gianluca PiatelliDipartimento Integrato Neuroscienze Mediche e Chirurgiche e Riabilitazione-Continuità Cure; U.O.C. Neurochirurgia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Edoardo ErrichielloUnit of Medical Genetics, Department of Molecular Medicine, University of Pavia, Pavia, Italy and Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, Italy.ORCID 0000-0001-6346-1988
Antigone S PapavasiliouDepartment of Neurology, IASO Children's Hospital, Athens, Greece.
Georgia VasileiouInstitute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
André ReisInstitute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Bradley PrinceDepartment of Medical Genetics, University of Calgary, Calgary, Canada.
Scott E HickeyDivision of Genetics and Genomics, Nationwide Children's Hospital, Columbus, Ohio, USA.
Daniel C KoboldtDepartment of Pediatrics, The Ohio State College of Medicine, Columbus, Ohio, USA.ORCID 0000-0003-3204-3067
Michael C SchneiderCarle Physicians Group, Section of Neurology, St. Christopher's Hospital for Children, Urbana, Illinois, USA.
Joseph PorrmannInstitute for Clinical Genetics, University Hospital TU Dresden, Dresden, Germany.
Nataliya Di DonatoInstitute for Clinical Genetics, University Hospital TU Dresden, Dresden, Germany.
Thomas LeisDepartment of Pediatrics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
M Scott PerryJane and John Justin Institute for Mind Health, Fort Worth, Texas, USA.
Jennifer HumbersonGenetics, University of Virginia Community Health Pediatric Specialty Care, Charlottesville, Virginia, USA.
Joshua RotenbergMemorial Hermann Memorial City Medical Center, Houston, Texas, USA.
Somayeh BakhtiariPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Helen MageePediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Shaydah KheradmandGeneDx, LLC, Gaithersburg, Maryland, USA.
Michael C KruerPediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Andrew SwaleNorth West Genomic Laboratory Hub (Liverpool), Manchester Centre for Genomic Medicine, Liverpool Women's Hospital, Liverpool, UK.
Astrid WeberLiverpool Women's Hospital, Liverpool, UK.
Caren LandesAlder hey Children's NHS Foundation Trust, Liverpool, UK.
Orsetta ZuffardiUnit of Medical Genetics, Department of Molecular Medicine, University of Pavia, Pavia, Italy and Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, Italy.
Livia GaravelliMedical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.ORCID 0000-0002-7684-3982
Arie van HaeringenDepartment of Clinical Genetics, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
Claudia A L RuivenkampDepartment of Clinical Genetics, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
Melissa PaulyInstitute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Ping Yee Billie AuDepartment of Medical Genetics, University of Calgary, Calgary, Canada.
William B DobynsDepartment of Pediatrics (Genetics), University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-7681-2844
Kimberly A AldingerNorcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, USA.ORCID 0000-0002-5406-8911

Funding

The Genetic Basis of Mid-Hindbrain MalformationsR01NS050375 · NINDS · UNIVERSITY OF MINNESOTA · PI DOBYNS, WILLIAM B. · 2005 to 2019
$9.9M
Genomic analysis of the Multiplex, Autozygous Populations in Cerebral Palsy (MAP CP) cohort: a focused approach to a complex diseaseR01NS127108 · NINDS · UNIVERSITY OF ARIZONA · PI Michael C Kruer · 2023 to 2026
$2.6M
NIH HHS 1R01NS050375NINDS NIH HHS R01 NS050375NINDS NIH HHS R01 NS127108Wellcome TrustWellcome Trust WT223718/Z/21/Z
6 · The paper itself

Abstract

Haploinsufficiency of AUTS2 is associated with a neurodevelopmental disorder characterized by intellectual disability, autistic features, and spasticity. AUTS2 protein interacts with p300, encoded by EP300, through the HX repeat domain of AUTS2, thereby activating transcription. We previously reported two de novo variants in the HX repeat domain of AUTS2. These variants disrupt the AUTS2-P300 interaction, resulting in a phenotype resembling Rubinstein-Taybi Syndrome (RSTS) associated with variants in EP300/CREBBP. Here, we expand beyond the initial clinical description to delineate the HX domain-associated phenotype and compare it to the AUTS2-haploinsufficient phenotype. We reviewed clinical data, photographs, and neuroimaging studies to examine genotype-phenotype relationships. Our review of 80 individuals included 14 individuals we present here and 66 individuals with AUTS2 variants presented in the literature. The clinical features for individuals with variants in the HX repeat domain include severe intellectual disability, severe language disability, distinct craniofacial and skeletal dysmorphic features, and neuroimaging findings. Facial dysmorphisms include wide and prominent nasal bridges with complex nasal shapes and dysmorphic eyebrows. Dysmorphisms include digit anomalies: Symphalangism and hypoplasia of distal phalanges, exclusive to the HX domain variant group. Cerebellar anomalies not seen with other AUTS2 variants are seen within this group. Our report delineates a distinct and severe clinical phenotype associated with variants in the AUTS2 HX domain, including an in-depth comparison with the AUTS2 haploinsufficiency phenotype features.

Indexed as

Cytoskeletal ProteinsIntellectual DisabilityRubinstein-Taybi SyndromeTranscription FactorsAdolescentAdultChildChild, PreschoolE1A-Associated p300 ProteinFemaleGenetic Association StudiesHaploinsufficiencyHumansMaleMutationPhenotypeAUTS2 protein, humanCytoskeletal ProteinsE1A-Associated p300 ProteinEP300 protein, humanTranscription FactorsAUTS2genotype‐phenotypehuman genetics

Identifiers

PMID40317680
PMCPMC12339213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.